ScripShanghai Belief BioMed’s (BBM) gene therapy, BBM-H901, an adeno-associated virus vector (AAV) carrying the human factor IX (FIX) gene, has shown favorable efficacy and safety in adults with hemophilia
ScripWith a steep climb in second-quarter sales and just-released promising data in heart failure, Bayer AG 's mineralocorticoid receptor antagonist Kerendia is finally looking like a candidate to fill th
ScripCurrent treatments for Parkinson's still only provide symptomatic relief but Bayer AG is hopeful that a couple of its cell and gene therapies being developed by its wholly owned subsidiaries BlueRo
ScripBayer AG is undergoing a transformation in organizational structure and culture and the dynamic shared ownership (DSO) model championed by CEO Bill Anderson is having an impact on the German group's